Publicacións nas que colabora con Juan Carlos Leza Cerro (24)

2024

  1. Association between neutrophil to lymphocyte ratio and inflammatory biomarkers in patients with a first episode of psychosis

    Journal of Psychiatric Research, Vol. 172, pp. 334-339

  2. Probing the oral-brain connection: oral microbiome patterns in a large community cohort with anxiety, depression, and trauma symptoms, and periodontal outcomes

    Translational Psychiatry, Vol. 14, Núm. 1

2023

  1. Association of Prolactin, Oxytocin, and Homocysteine With the Clinical and Cognitive Features of a First Episode of Psychosis Over a 1-Year Follow-Up

    International Journal of Neuropsychopharmacology, Vol. 26, Núm. 11, pp. 796-807

2022

  1. Inflammation biomarkers in suicide attempts and their relation to abuse, global functioning and cognition

    World Journal of Biological Psychiatry, Vol. 23, Núm. 4, pp. 307-317

  2. The Influence of Oxytocin and Prolactin During a First Episode of Psychosis: The Implication of Sex Differences, Clinical Features, and Cognitive Performance

    The international journal of neuropsychopharmacology, Vol. 25, Núm. 8, pp. 666-677

  3. The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study

    European Neuropsychopharmacology, Vol. 57, pp. 105-117

2021

  1. Gut microbiota, innate immune pathways, and inflammatory control mechanisms in patients with major depressive disorder

    Translational Psychiatry, Vol. 11, Núm. 1

2020

  1. Functionality and Neurocognition in Patients With Bipolar Disorder After a Physical-Exercise Program (FINEXT-BD Study): Protocol of a Randomized Interventionist Program

    Frontiers in Psychiatry, Vol. 11

2019

  1. Association between medication adherence and oxidative stress in patients with first-episode mania

    Frontiers in Psychiatry, Vol. 10, Núm. MAR

  2. CIBERSAM: Ten years of collaborative translational research in mental disorders

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 1, pp. 1-8

  3. Differences in the regulation of inflammatory pathways in adolescent- and adult-onset first-episode psychosis

    European Child and Adolescent Psychiatry, Vol. 28, Núm. 10, pp. 1395-1405

2018

  1. Cardiovascular Risk in Early Psychosis: Relationship with Inflammation and Clinical Features 6 Months after Diagnosis

    International Journal of Neuropsychopharmacology, Vol. 21, Núm. 5, pp. 410-422

2016

  1. BDNF and NGF Signalling in Early Phases of Psychosis: Relationship with Inflammation and Response to Antipsychotics after 1 Year

    Schizophrenia Bulletin, Vol. 42, Núm. 1, pp. 142-151

  2. Cognition and psychopathology in first-episode psychosis: Are they related to inflammation?

    Psychological Medicine, Vol. 46, Núm. 10, pp. 2133-2144

  3. Dysregulated peripheral endocannabinoid system signaling is associated with cognitive deficits in first-episode psychosis

    Journal of Psychiatric Research, Vol. 75, pp. 14-21

2015

  1. Discrimination between Alzheimer's disease and late onset bipolar disorder using multivariate analysis

    Frontiers in Aging Neuroscience, Vol. 7, Núm. DEC

  2. Pro-/antiinflammatory dysregulation in early psychosis: Results from a 1-year follow-Up study

    International Journal of Neuropsychopharmacology, Vol. 18, Núm. 2, pp. 1-10

2014

  1. Basal low antioxidant capacity correlates with cognitive deficits in early onset psychosis. A 2-year follow-up study

    Schizophrenia Research, Vol. 156, Núm. 1, pp. 23-29

  2. Birth weight, working memory and epigenetic signatures in IGF2 and related genes: A MZ twin study

    PLoS ONE, Vol. 9, Núm. 8

  3. Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: Toward an integrative inflammatory hypothesis of schizophrenia

    Schizophrenia Bulletin, Vol. 40, Núm. 2, pp. 376-387